Tiba Aynechi is a General Partner at Norwest Venture Partners where she invests in biotechnology, therapeutics, life sciences, medtech, and healthcare IT companies. She invests across early- and mid-stage venture and growth equity, including Series A, Series B, and Series D, and across the United States, Europe (including the United Kingdom), India, and Israel. She invests from Norwest’s $3bn fund raised in December 2021. She serves on the boards of Mosanna Therapeutics, Engrail Therapeutics, Ray Therapeutics, MBX Biosciences, and Rezo Therapeutics, and has invested in companies like Spruce Biosciences, Avalyn Pharmaceuticals, Nkarta Therapeutics, Aristea Therapeutics, and Ray Therapeutics. Tiba holds degrees from the University of California, San Francisco and UC Irvine, and lives in the San Francisco Bay Area.
Tiba Aynechi, General Partner @ Norwest. Profile with intro opportunities and ranking information.
Not Yet Mapped
We've created a profile for Tiba Aynechi from Norwest. Our ranking analysis and additional data will be available once our research is complete.
Rankings and detailed information coming soon
Network Strength
No ranking data available yet.
How to get an intro to Tiba
Map your path to Tiba instantly
Connect your network and Draftboard will automatically find and score the strongest paths to Tiba
That's it. Draftboard does the rest.
Rankings based on connection strength analysis - we ONLY show aggregate data, never specific connection data.